CNS Neuroscience & Therapeutics

自2025年1月1日起，所有投稿和审稿必须遵守人工智能（AI）指南；本刊采用Wiley关于研究诚信与出版伦理——人工智能的最佳实践指南。 模型中文摘要

From 1st January 2025, all submissions and reviews must adhere to artificial intelligence (AI) guidelines. Note: CNS Neuroscience & Therapeutics adopts Wiley’s Best Practice Guidelines on Research Integrity and Publishing Ethics – Artificial Intelligence.

本刊遵循国际医学期刊编辑委员会（ICMJE）对作者身份的定义，作者身份基于四项标准：对工作的构思或设计或数据获取、分析、解释作出实质性贡献；起草或批判性修改工作；对将发表的版本作最终批准；同意对工作的所有方面负责。 模型中文摘要

The journal adheres to the definition of authorship set up by The International Committee of Medical Journal Editors (ICMJE). The ICMJE recommends that authorship be based on the following 4 criteria: i) Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; ii) Drafting the work or revising it critically for importa…

所有稿件必须在正文中包含利益冲突声明，声明任何可能构成利益冲突的财务支持或关系，包括作者与产品在稿件中占重要地位的公司或竞争产品公司之间的财务安排；无利益可披露时也须说明；声明应置于“Disclosure”标题下，位于“Acknowledgement”部分之后、“References”部分之前。 模型中文摘要

All manuscripts must include a disclosure statement in the body of the manuscript. The statement must declare any financial support or relationships that may pose conflict of interest. This includes any financial arrangements authors have with a company whose product figures prominently in the submitted manuscript or with a company making a competing product. The absence of any interest to disclos…

作者须提供数据可用性声明，确认是否共享数据；若共享数据，声明应说明数据如何获取，并包含存储库的持久标识符（如DOI或登录号）；作者须确认遵守该政策；发表后声明将置于稿件标题区。 模型中文摘要

A statement to confirm the presence or absence of shared data. If authors have shared data, this statement will describe how the data can be accessed, and include a persistent identifier (e.g., a DOI for the data, or an accession number) from the repository where you shared the data. Authors will be required to confirm adherence to the policy. Sample statements are available here. If published, al…

本刊是出版伦理委员会（COPE）成员，并遵循其原则。 模型中文摘要

The journal is a member of, and subscribes to the principles of the Committee on Publication Ethics (COPE).

如引用第三方版权作品的摘录，须在稿件中注明出处；作者有责任获得版权所有者的书面复制许可。 模型中文摘要

If excerpts from copyrighted works owned by third parties are included, credit must be shown in the contribution. It is the author’s responsibility to also obtain written permission for reproduction from the copyright owners. For more information visit Wiley’s Copyright Terms & Conditions FAQ at http://exchanges.wiley.com/authors/faqs---copyright-terms--conditions_301.html

本页列出相关开放获取健康科学期刊：Animal Models and Experimental Medicine（2018年至今）、Brain Pathology（1990年至今）、Ibrain（2020年至今）、Neuroprotection（2022年至今）、Brain-X（2023年至今）。 模型中文摘要

Animal Models and Experimental Medicine (2018-Present)Brain Pathology (1990-Present)Ibrain (2020-Present)Neuroprotection (2022-Present)Brain-X (2023-Present)

本刊为中枢神经系统治疗相关研究提供快速发表平台，聚焦卒中等神经与精神疾病；本刊参与NISO同行评审术语工作组试点，以标准化描述同行评审实践的术语。 模型中文摘要

CNS Neuroscience & Therapeutics provides a medium for rapid publication of original clinical, experimental, and translational research papers, timely reviews and reports of novel findings of therapeutic relevance to the central nervous system, as well as papers related to clinical pharmacology, drug development and novel methodologies for drug evaluation. The journal focuses on neurological and ps…

本刊采用查重系统；向本刊投稿即表示接受稿件可能被筛查是否与已发表作品存在抄袭。 模型中文摘要

The journal employs a plagiarism detection system. By submitting your manuscript to this journal you accept that your manuscript may be screened for plagiarism against previously published works.